New on this website

02.06.2023

Assistent/in – Fachliche Betreuung Drug Safety System (80-100%)

Job advertisement | Einheit Pharmacovigilance der Abteilung Arzneimittelsicherheit (AMS)

02.06.2023

Fachassistent/in klinische Versuche Medizinprodukte (80-100%)

Job advertisement | Division Medical Devices Clinical Investigations

01.06.2023

Change to the veterinary medicinal product package leaflet template

Clarification in section 13 of the veterinary medicinal product package leaflet template

01.06.2023

Delayed implementation time limits for replacement changes

Changes to the guidance documents Variations and Extensions HMP and Variations VMP

30.05.2023

Swissmedic Vigilance-News Edition 30

In this edition: Checkpoint inhibitors: pregnancy-related outcomes; JAK inhibitors: risk minimisation / dosage individualisation; COVID-19 vaccines: myocarditis in elderly patients / adverse reactions after vaccination with bivalent vaccines; Haemovigilance: incorrect blood component transfused and near misses

30.05.2023

The latest issue of “Visible” is here!

In the 7th issue of the Swissmedic magazine “Visible”, we explain the requirements a medicinal product has to meet before it is authorised, Swissmedic's strategic objectives for the next four years, and much more. We hope you enjoy reading it!

26.05.2023

Einheitsleiter/in GCP/GVP-Inspektorat (80-100%)

Job advertisement | Abteilung Klinische Versuche

26.05.2023

Spitalinspektor/in (80-100%)

Job advertisement | Division Medical Devices Operations and Hospitals

26.05.2023

Out-of-Stock – Jemperli Konzentrat zur Herstellung einer Infusionslösung

Befristete Bewilligung zum Vertrieb in britischer Aufmachung

26.05.2023

Public Summary SwissPAR – Tecvayli®

First authorisation

26.05.2023

Public Summary SwissPAR – Nubeqa®

Extension of therapeutic indication (01)
Permanent link of this page
www.swissmedic.ch/updates-en
News channel of this page

Last modification 13.02.2020

Top of page